Walgreen’s reported good fiscal fourth quarter results, including a significant growth in prescriptions filled. The Company also discussed its efforts to expand its services for chronic disease and for wellness programs, including use of its retail clinics. Walgreen’s recently did a direct to employer arrangement with Caterpillar for prescription drugs, which it hopes to replicate. It is also aggressively marketing 90 day prescriptions, usually used for chronic disease treatment, to better compete with mail order pharmacies and PBMs. The Company indicated it might seek additional acquisitions to fill out its health services offerings. Walgreen’s also plans to begin selling wine and beer in its stores, although its hard to figure out the health angle there. Walgreen’s is worth tracking closely because not only is it a large pharmacy player but it has been innovative in trying to expand beyond its core to additional services for employers and payers, as well as consumers. (Walgreen’s Transcript)
✅ Subscribe via Email
About this Blog
The Healthy Skeptic is a website about the health care system, and is written by Kevin Roche, who has many years of experience working in the health industry. Mr. Roche is available to assist health care companies through consulting arrangements through Roche Consulting, LLC and may be reached at [email protected].
Healthy Skeptic Podcast
This is an outstanding report on total global drug spending and trends, with projections out to 2025. It helps you understand this important area of health care, which does much...
June 1, 2021
MedPAC 2019 Report to Congress
June 18, 2019
Mercer, a large benefits consulting firm, confirms that health plan premiums are rising in 2023, publishing survey results showing that employers expect an increase of costs by at least 5%....
December 9, 2022
More money pouring into young health care companies as Dispatch Health gains $330 million in new capital to deliver high acuity health care in a patient’s home, rather than a...
November 30, 2022
A lot of money is invested in health care startups and growth companies, since health care is 20% of the economy, but the returns aren’t always good. Here is another...
November 1, 2022
Access ACO Care Management Chronic Disease Comparative Effectiveness Consumer Directed Health Consumers Devices Disease Management Drugs EHRs Elder Care End-of-Life Care FDA Financings Genomics Government Health Care Costs Health Care Quality Health Care Reform Health Insurance Health Insurance Exchange HIT HomeCare Hospital Hospital Readmissions Legislation M&A Malpractice Meaningful Use Medicaid Medical Care Medicare Medicare Advantage Mobile Pay For Performance Pharmaceutical Physicians Providers Regulation Repealing Reform Telehealth Telemedicine Wellness and Prevention Workplace